Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2023-04-24 00:00:00 ET · period of report 2023-04-24 · accession 0001209191-23-025473 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-24 | 2023-04-24 | VKTX | MACARTNEY LAWSON | Dir | M - OptEx | $3.33 | +16.0K | 64.0K | +33% | +$53.3K |
| D | 2023-04-24 | 2023-04-24 | VKTX | MACARTNEY LAWSON | Dir | S - Sale+OE | $22.00 | -16.0K | 48.0K | -25% | -$352.0K |
| D | 2023-04-24 | 2023-04-24 | VKTX | MACARTNEY LAWSON | Dir | M - OptEx | $0.00 | -16.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2023-04-24 | M | A | 16,000 | $3.33 | 63,965 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2023-04-24 | S | D | 16,000 | $22.00 | 47,965 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-04-24 | M | D | 16,000 | $0.00 | 0 | D | $3.33 · 2017-01-04 to 2026-01-04 | 16,000 Common Stock |